cannabinoids

TORONTO, June 22, 2023 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a commercial stage, international biopharmaceutical company focused on the commercialization of evidence-based,…

LISBON, Portugal, June 12, 2023 (GLOBE NEWSWIRE) -- SOMAÍ Pharmaceuticals Unipessoal LDA (“SOMAÍ”) has entered into a two-year supply agreement with a well-respected Polish distributor Cosma Cannabis. Cosma produces medical-grade…

Marijuana (cannabis) is well known for giving people the "munchies." Not only does it make people want to eat more, but it also makes them crave the tastiest, most high-calorie foods. Now a new study in the journal Current Biology on April…

Bronchial constriction is what makes many lung diseases like asthma so dangerous. Researchers have discovered a new signalling pathway that causes the airways to widen. Inhalation therapy for asthma and other obstructive lung diseases often…

“We’ve actually gone a little overboard with the quality… sacrificing profit to launch a product that surpasses the quality of most Delta 8 disposables”…

HENDERSON, Nev., Aug. 24, 2022 (GLOBE NEWSWIRE) -- BioLife Sciences Inc. (“BioLife” or the “Company”) (OTC: BLFE) announced today that it will be expanding the scope of its orthomolecular medicine and natural health products division,…

For the first time, plant biologists have defined the high-efficiency "hacks" that cannabis cells use to make cannabinoids (THC/CBD). Although many biotechnology companies are currently trying to engineer THC/CBD outside the plant in yeast…

THC-H Distillate "These new cannabinoids will be the next big thing in Japan. As the current cannabinoids become banned in Japan, these new rare cannabinoids…

VANCOUVER, British Columbia, June 14, 2022 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, today…

Physician’s Briefing Staff MONDAY, June 6, 2022 (HealthDay News) -- Oral synthetic cannabinoid products with high tetrahydrocannabinol (THC)-to-cannabidiol (CBD) ratios are associated with moderate…